FibroGen (FGEN) Tops Q1 EPS by 1c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.50), $0.01 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $31.93 million versus the consensus estimate of $27.15 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Citigroup (C) Tops Q2 EPS by 42c
• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue